Tigecycline patents expiration

Can you believe TIGECYCLINE received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9855335 AMNEAL Tigecycline composition for injection
Apr, 2033

(9 years from now)

Tigecycline is owned by Amneal.

Tigecycline contains Tigecycline.

Tigecycline has a total of 1 drug patent out of which 0 drug patents have expired.

Tigecycline was authorised for market use on 02 August, 2018.

Tigecycline is available in powder;intravenous dosage forms.

The generics of Tigecycline are possible to be released after 07 April, 2033.

Drugs and Companies using TIGECYCLINE ingredient

Market Authorisation Date: 02 August, 2018

Treatment: NA


More Information on Dosage

TIGECYCLINE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic